Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Sanofi
Ownership Structure: publicly traded
Headquartered in: France
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $1,348,822,885
Number of records: 38
Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
safety-related offenses | $513,794,039 | 4 |
government-contracting-related offenses | $489,458,415 | 15 |
competition-related offenses | $328,497,768 | 14 |
employment-related offenses | $15,360,000 | 1 |
consumer-protection-related offenses | $1,600,000 | 1 |
Top 5 Primary Offense Types | Penalty Total | Number of Records |
False Claims Act and related | $489,458,415 | 15 |
product safety violation | $458,006,000 | 1 |
price-fixing or anti-competitive practices | $302,680,768 | 12 |
drug or medical equipment safety violation | $55,781,039 | 2 |
Foreign Corrupt Practices Act | $25,200,000 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: For a summary of this company's regulatory penalties in more than 50 other countries, see its Violation Tracker Global summary page
here.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
Company | Primary Offense Type | Year | Agency | Penalty Amount |
Sanofi | product safety violation | 2024 | HI-AG | $458,006,000 |
Aventis Pharmaceuticals Inc. | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
Sanofi-Aventis U.S. Inc. | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
Aventis Pharmaceutical Inc. | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Sanofi Pasteur Inc. | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $61,500,000 |
Hoechst Marion Roussel | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Hoechst Marion Roussel, Inc. | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Aventis Pharmaceutical Inc. | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Hoechst AG | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
Genzyme Corporation | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
Roussel Uclaf S.A. | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Genzyme Corp. | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
Genzyme Corp. | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Sanofi-Pasteur | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Sanofi-Aventis U.S. LLC | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
Aventis Pharmaceutical L.P. | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
Hoechst AG | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Sanofi-Aventis U.S., LLC | False Claims Act and related | 2020 | USAO | $11,850,000 |
Aventis Pharmaceuticals Inc. | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Hoechst Marion Roussel | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Aventis Pharmaceuticals, Inc. | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Sanofi-Aventis | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Aventis Pharmaceuticals Inc. | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Sanofi-Aventis U.S. LLC | False Claims Act and related | 2012 | ID-AG | $828,500 |
Aventis Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
Sanofi US Services, Inc. | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
IMO SANOFI PASTEUR | environmental violation | 2014 | EPA | $77,643 |
SANOFI PASTEUR | environmental violation | 2006 | PA-ENV | $28,620 |
SANOFI PASTEUR INC. | workplace safety or health violation | 2014 | OSHA | $7,000 |
SANOFI PASTEUR | environmental violation | 2007 | PA-ENV | $6,400 |